Annual SGA
$105.86 M
+$92.38 M+685.26%
December 1, 2024
Summary
- As of March 12, 2025, SLNO annual SGA is $105.86 million, with the most recent change of +$92.38 million (+685.26%) on December 1, 2024.
- During the last 3 years, SLNO annual SGA has risen by +$95.06 million (+879.65%).
- SLNO annual SGA is now at all-time high.
Performance
SLNO SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$37.30 M
-$11.89 M-24.18%
December 1, 2024
Summary
- As of March 12, 2025, SLNO quarterly SGA is $37.30 million, with the most recent change of -$11.89 million (-24.18%) on December 1, 2024.
- Over the past year, SLNO quarterly SGA has stayed the same.
- SLNO quarterly SGA is now -24.18% below its all-time high of $49.20 million, reached on September 30, 2024.
Performance
SLNO Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.47 B
-$175.85 M-13.63%
December 1, 2024
Summary
- As of March 12, 2025, SLNO TTM SGA is -$1.47 billion, with the most recent change of -$175.85 million (-13.63%) on December 1, 2024.
- Over the past year, SLNO TTM SGA has dropped by -$1.57 billion (-1484.84%).
- SLNO TTM SGA is now -2467.42% below its all-time high of -$57.10 million.
Performance
SLNO TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
SLNO Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +685.3% | 0.0% | -1484.8% |
| 3 y3 years | +879.6% | 0.0% | -1484.8% |
| 5 y5 years | +1427.6% | 0.0% | -1484.8% |
SLNO Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +975.4% | -24.2% | +1499.6% | -79.3% | at low |
| 5 y | 5-year | at high | +1427.6% | -24.2% | +2219.8% | -153.1% | at low |
| alltime | all time | at high | +9291.5% | -24.2% | >+9999.0% | -2467.4% | at low |
Soleno Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $105.86 M(+685.3%) | $37.30 M(-24.2%) | $105.86 M(+45.6%) |
| Sep 2024 | - | $49.20 M(+351.8%) | $72.70 M(+171.1%) |
| Jun 2024 | - | $10.89 M(+28.5%) | $26.82 M(+40.4%) |
| Mar 2024 | - | $8.47 M(+104.6%) | $19.10 M(+41.7%) |
| Dec 2023 | $13.48 M(+36.9%) | $4.14 M(+24.8%) | $13.48 M(+14.8%) |
| Sep 2023 | - | $3.32 M(+4.7%) | $11.74 M(+9.2%) |
| Jun 2023 | - | $3.17 M(+11.0%) | $10.76 M(+7.0%) |
| Mar 2023 | - | $2.85 M(+18.8%) | $10.05 M(+2.1%) |
| Dec 2022 | $9.84 M(-8.9%) | $2.40 M(+3.0%) | $9.84 M(-1.9%) |
| Sep 2022 | - | $2.33 M(-5.5%) | $10.04 M(-4.2%) |
| Jun 2022 | - | $2.47 M(-6.7%) | $10.47 M(+0.0%) |
| Mar 2022 | - | $2.64 M(+1.8%) | $10.47 M(-3.1%) |
| Dec 2021 | $10.81 M(+23.4%) | $2.60 M(-6.2%) | $10.81 M(+3.3%) |
| Sep 2021 | - | $2.77 M(+12.3%) | $10.46 M(+5.1%) |
| Jun 2021 | - | $2.46 M(-17.3%) | $9.95 M(+2.2%) |
| Mar 2021 | - | $2.98 M(+32.3%) | $9.73 M(+11.1%) |
| Dec 2020 | $8.76 M(+26.4%) | $2.25 M(-0.2%) | $8.76 M(+7.9%) |
| Sep 2020 | - | $2.26 M(+0.4%) | $8.12 M(+8.6%) |
| Jun 2020 | - | $2.25 M(+12.2%) | $7.47 M(+8.0%) |
| Mar 2020 | - | $2.00 M(+24.6%) | $6.92 M(-0.1%) |
| Dec 2019 | $6.93 M(+5.7%) | $1.61 M(-0.4%) | $6.93 M(+3.6%) |
| Sep 2019 | - | $1.61 M(-4.7%) | $6.69 M(+0.9%) |
| Jun 2019 | - | $1.70 M(-15.8%) | $6.63 M(-1.1%) |
| Mar 2019 | - | $2.01 M(+47.4%) | $6.70 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $6.56 M(-0.8%) | $1.36 M(-12.4%) | $6.56 M(-4.6%) |
| Sep 2018 | - | $1.56 M(-11.8%) | $6.88 M(-1.8%) |
| Jun 2018 | - | $1.77 M(-5.4%) | $7.00 M(-5.8%) |
| Mar 2018 | - | $1.87 M(+10.9%) | $7.43 M(+12.4%) |
| Dec 2017 | $6.61 M(+8.8%) | $1.68 M(-0.1%) | $6.61 M(+2.1%) |
| Sep 2017 | - | $1.69 M(-23.2%) | $6.47 M(+7.0%) |
| Jun 2017 | - | $2.19 M(+109.8%) | $6.05 M(+11.2%) |
| Mar 2017 | - | $1.05 M(-32.3%) | $5.44 M(-20.8%) |
| Dec 2016 | $6.08 M(-22.9%) | $1.54 M(+22.6%) | $6.87 M(-8.8%) |
| Sep 2016 | - | $1.26 M(-20.7%) | $7.53 M(-10.9%) |
| Jun 2016 | - | $1.59 M(-35.9%) | $8.45 M(-4.0%) |
| Mar 2016 | - | $2.48 M(+12.2%) | $8.80 M(+11.7%) |
| Dec 2015 | $7.88 M(+170.0%) | $2.21 M(+1.2%) | $7.88 M(+14.1%) |
| Sep 2015 | - | $2.18 M(+12.5%) | $6.91 M(+29.5%) |
| Jun 2015 | - | $1.94 M(+24.9%) | $5.33 M(+28.4%) |
| Mar 2015 | - | $1.55 M(+25.5%) | $4.15 M(+42.6%) |
| Dec 2014 | $2.92 M(+98.9%) | $1.24 M(+104.0%) | $2.91 M(+55.3%) |
| Sep 2014 | - | $606.00 K(-20.1%) | $1.88 M(+23.6%) |
| Jun 2014 | - | $758.00 K(+142.9%) | $1.52 M(+11.3%) |
| Mar 2014 | - | $312.00 K(+56.0%) | $1.36 M(-7.1%) |
| Dec 2013 | $1.47 M(+30.1%) | $200.00 K(-19.4%) | $1.47 M(+15.8%) |
| Sep 2013 | - | $248.00 K(-58.9%) | $1.27 M(+24.3%) |
| Jun 2013 | - | $604.10 K(+45.3%) | $1.02 M(+145.3%) |
| Mar 2013 | - | $415.90 K | $415.90 K |
| Dec 2012 | $1.13 M | - | - |
FAQ
- What is Soleno Therapeutics annual SGA?
- What is the all time high annual SGA for Soleno Therapeutics?
- What is Soleno Therapeutics annual SGA year-on-year change?
- What is Soleno Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly SGA year-on-year change?
- What is Soleno Therapeutics TTM SGA?
- What is the all time high TTM SGA for Soleno Therapeutics?
- What is Soleno Therapeutics TTM SGA year-on-year change?
What is Soleno Therapeutics annual SGA?
The current annual SGA of SLNO is $105.86 M
What is the all time high annual SGA for Soleno Therapeutics?
Soleno Therapeutics all-time high annual SGA is $105.86 M
What is Soleno Therapeutics annual SGA year-on-year change?
Over the past year, SLNO annual SGA has changed by +$92.38 M (+685.26%)
What is Soleno Therapeutics quarterly SGA?
The current quarterly SGA of SLNO is $37.30 M
What is the all time high quarterly SGA for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly SGA is $49.20 M
What is Soleno Therapeutics quarterly SGA year-on-year change?
Over the past year, SLNO quarterly SGA has changed by $0.00 (0.00%)
What is Soleno Therapeutics TTM SGA?
The current TTM SGA of SLNO is -$1.47 B
What is the all time high TTM SGA for Soleno Therapeutics?
Soleno Therapeutics all-time high TTM SGA is -$57.10 M
What is Soleno Therapeutics TTM SGA year-on-year change?
Over the past year, SLNO TTM SGA has changed by -$1.57 B (-1484.84%)